Ozanimod (RPC-1063) (RPC1063) is a specific oral S1P Receptor 1 modulator. Ozanimod has been used in trials studying the treatment of Crohns Disease, Ulcerative Colitis, Multiple Sclerosis, and Relapsing Multiple Sclerosis.
Molecular Weight:
404.46
Purity:
99.74%
CAS Number:
[1306760-87-1]
Formula:
C23H24N4O3
Target:
S1P Receptor|||LPL Receptor
T6923
* VAT and and shipping costs not included. Errors and price changes excepted